CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA)
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 15000 participants.
Also called NCT07220304
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 15,000 participants
- Sponsor
- Corazon Medical PC
- Registry
-
NCT07220304
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07220304. Allocation not applicable; no masking; primary purpose diagnostic. Start 2025-12 (anticipated); primary completion 2028-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CaRi-Heart Assessment of Risk and Evaluation of Inflammation in Coronary CT Angiography (CARE-CCTA)
- Acronym
- CARE-CCTA
- Condition
- Coronary Artery Disease
- Condition
- Atherosclerosis
- Condition
- Cardiovascular Inflammation
- Intervention (Device)
- CaRi-Heart® Analysis
- Lead sponsor
- Corazon Medical PC
Record details
- Record id
cardio:ct-nct07220304- Content hash
d32377577960b42ebb2f795720c59efce76407429ae930d818b2387d57fb770b